Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials /

Clowse Megan E. B., Wallace Daniel J., Furie Richard A., Petri Michelle A., Pike Marilyn C., Leszczynski Piotr, Neuwelt C. Michael, Hobbs Kathryn, Keiserman Mauro, Duca Liliana, Kalunian Kenneth C., EMBODY Investigator Group, Gasztonyi Beáta, Géher Pál, Kemény Lajos, Kiss Emese, Kovács László, Szűcs Gabriella, et al
2017